The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.

Nettersheim, Daniel

The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression. [electronic resource] - Genes, chromosomes & cancer Dec 2011 - 1033-42 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1098-2264

10.1002/gcc.20918 doi


Apoptosis--drug effects
Azacitidine--analogs & derivatives
Cell Differentiation--drug effects
Cell Line, Tumor
Decitabine
Depsipeptides--pharmacology
Down-Regulation--drug effects
Drug Resistance, Neoplasm
Endoderm--drug effects
Gene Knockdown Techniques--methods
Histone Deacetylase Inhibitors--pharmacology
Histone Deacetylases--metabolism
Homeodomain Proteins--biosynthesis
Humans
Male
Nanog Homeobox Protein
Octamer Transcription Factor-3--genetics
SOXF Transcription Factors--genetics
Seminoma--drug therapy
Testicular Neoplasms--drug therapy
Transcription Factor AP-2--genetics
Tranylcypromine--pharmacology
Tretinoin--pharmacology
Up-Regulation--drug effects